Evidence map›Paper›PMID 40092843›Full record

ArticleCell investigation2025

The role of YTHDF2 in anti-tumor immunity.

Lianjun Zhang, Cunte Chen, Jia Feng, Hongyu Zhang, Le Xuan Truong Nguyen, Zhenhua Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. mFrontiers in cell and developmental biology · 2026
    Review
  4. RNA mCell investigation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lianjun ZhangDepartment of Hematological Malignancies Translational Science, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Cunte ChenDepartment of Hematology, Guangzhou First People's Hospital, Institute of Blood Transfusion and Hematology, Guangzhou Medical University, Guangzhou 510180, China.
Jia FengDepartment of Hematology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Hongyu ZhangDepartment of Hematology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.
Le Xuan Truong NguyenDepartment of Hematological Malignancies Translational Science, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Zhenhua ChenDepartment of Systems Biology, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.

Funding

Targeting MicroRNAs to Eradicate Leukemia Stem CellsR01CA205247 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI, MARCUCCI, GUIDO · 2017 to 2025
$4.8M
NCI NIH HHS R01 CA205247
6 · The paper itself

Abstract

RNA

Indexed as

B cell malignanciesCD19 CAR TImmune responseM5CM6AMHCRNA modificationSelective inhibitorTumor microenvironmentYTHDF2

Identifiers

PMID40092843
PMCPMC11908620

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.